eHealth, Inc. (FRA:M5V)
Germany · Delayed Price · Currency is EUR 2.500
-0.310 (-11.03%)
Last updated: Jan 28, 2026, 9:04 AM CET
eHealth Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 476.55 | 461.65 | 403.92 | 361.25 | 493.12 | 508.19 |
Other Revenue | 66.4 | 70.76 | 48.95 | 44.11 | 45.08 | 74.59 |
| 542.95 | 532.41 | 452.87 | 405.36 | 538.2 | 582.77 | |
Revenue Growth (YoY) | 16.79% | 17.56% | 11.72% | -24.68% | -7.65% | 15.13% |
Cost of Revenue | 1.79 | 1.79 | 1.77 | 1.65 | 1.99 | 4.08 |
Gross Profit | 541.16 | 530.62 | 451.1 | 403.71 | 536.21 | 578.69 |
Selling, General & Admin | 435.55 | 444.05 | 421.57 | 408 | 530.39 | 458.69 |
Research & Development | 50.67 | 53.52 | 58.61 | 78.81 | 83.8 | 65.19 |
Amortization of Goodwill & Intangibles | - | - | - | - | 0.54 | 1.49 |
Operating Expenses | 486.21 | 497.57 | 480.17 | 486.81 | 614.73 | 525.37 |
Operating Income | 54.95 | 33.05 | -29.07 | -83.1 | -78.52 | 53.32 |
Interest Expense | -10.02 | -11.16 | -10.97 | -7.63 | -0.85 | - |
Interest & Investment Income | 4.7 | 7.2 | 8.4 | 2.8 | 0.2 | - |
Other Non Operating Income (Expenses) | -0.33 | -0.3 | 1.05 | 1.15 | 1.4 | 0.67 |
EBT Excluding Unusual Items | 49.29 | 28.79 | -30.6 | -86.77 | -77.77 | 53.99 |
Merger & Restructuring Charges | -1.14 | -2 | - | -7.51 | -4.88 | - |
Impairment of Goodwill | - | - | - | - | -40.2 | - |
Asset Writedown | -0.93 | -7.48 | - | -12.1 | -6.14 | - |
Other Unusual Items | - | - | - | - | 4.1 | - |
Pretax Income | 47.22 | 19.31 | -30.6 | -106.39 | -124.89 | 53.99 |
Income Tax Expense | -3.13 | 9.26 | -2.38 | -17.67 | -20.52 | 8.54 |
Net Income | 50.34 | 10.06 | -28.21 | -88.72 | -104.38 | 45.45 |
Preferred Dividends & Other Adjustments | 48.99 | 45.02 | 38.3 | 30.69 | 18.57 | - |
Net Income to Common | 1.35 | -34.96 | -66.52 | -119.41 | -122.94 | 45.45 |
Net Income Growth | - | - | - | - | - | -32.05% |
Shares Outstanding (Basic) | 30 | 29 | 28 | 27 | 27 | 26 |
Shares Outstanding (Diluted) | 30 | 29 | 28 | 27 | 27 | 27 |
Shares Change (YoY) | 4.00% | 4.71% | 2.40% | 2.16% | -0.86% | 10.09% |
EPS (Basic) | 0.04 | -1.19 | -2.37 | -4.36 | -4.59 | 1.75 |
EPS (Diluted) | 0.04 | -1.19 | -2.37 | -4.36 | -4.59 | 1.68 |
EPS Growth | - | - | - | - | - | -38.46% |
Free Cash Flow | -19.8 | -20.46 | -8.78 | -27.08 | -166.49 | -115.61 |
Free Cash Flow Per Share | -0.66 | -0.70 | -0.31 | -0.99 | -6.22 | -4.28 |
Gross Margin | 99.67% | 99.66% | 99.61% | 99.59% | 99.63% | 99.30% |
Operating Margin | 10.12% | 6.21% | -6.42% | -20.50% | -14.59% | 9.15% |
Profit Margin | 0.25% | -6.57% | -14.69% | -29.46% | -22.84% | 7.80% |
Free Cash Flow Margin | -3.65% | -3.84% | -1.94% | -6.68% | -30.93% | -19.84% |
EBITDA | 56.83 | 35.03 | -26.53 | -79.25 | -72.56 | 58.51 |
EBITDA Margin | 10.47% | 6.58% | -5.86% | -19.55% | -13.48% | 10.04% |
D&A For EBITDA | 1.89 | 1.98 | 2.54 | 3.85 | 5.97 | 5.19 |
EBIT | 54.95 | 33.05 | -29.07 | -83.1 | -78.52 | 53.32 |
EBIT Margin | 10.12% | 6.21% | -6.42% | -20.50% | -14.59% | 9.15% |
Effective Tax Rate | - | 47.92% | - | - | - | 15.82% |
Revenue as Reported | 542.95 | 532.41 | 452.87 | 405.36 | 538.2 | 582.77 |
Advertising Expenses | - | 164.2 | 148.7 | 169.1 | 240.4 | 178.9 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.